Background
Methods
Criteria for including studies
-
PROMs such as Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Oxford knee score (Oxford), Knee Society Score (KSS), and the Knee injury and Osteoarthritis Outcome Score (KOOS), European quality of life 5-dimensions using the visual analogue scale (EQ-5D VAS), 12-item short form health survey physical score (SF-12 physical score), 12-item short form health survey mental score (SF-12 mental score)
-
Transfusion rate
-
Blood loss
-
Surgery time
-
Complications (i.e. SSI, DVT, and revision TKA)
Results
Results of the search
Included studies
Author | Year | Country | Study design | Patients | %females | Age | Follow-up months | PSI device | CT/MRI | Eligibility criteria | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PSI | ST | PSI | ST | PSI | ST | ||||||||
Noble Jr. [7] | 2012 | USA | RCT | 15 | 14 | 47 | 57 | 65.4(57–76) | 68.0(56–80) | NR | Visionaire | MRI | arthritis |
Pietsch [34] | 2013 | Austria | RCT | 40 | 40 | 68 | 53 | 71.4(6.6) | 69.2(9.4) | 3 months | Materialise | MRI | OA |
Vundelinckx [35] | 2013 | Belgium | RCT | 31 | 31 | 52 | 65 | 64.7(8.2) | 68.2(8.5) | 6 months | Visionaire | MRI | OA |
Boonen [36] | 2013 | Netherlands | RCT | 90 | 90 | 62 | 56 | 69.0(8.0) | 65.0(8.8) | 44 months | Signature | MRI | OA |
Chareancholvanich [37] | 2013 | Thailand | RCT | 40 | 40 | 85 | 90 | 69.5(55–84) | 70.3(53–85) | NR | Materialise | MRI | OA |
Hamilton [38] | 2013 | USA | RCT | 26 | 26 | 46 | 73 | 68.1(52–86) | 67.6(51–88) | NR | TruMatch | CT | OA |
Roh [39] | 2013 | Korea | RCT | 42 | 48 | 93 | 90 | 70.0(7.2) | 70.0(5.1) | NR | Signature | CT | OA |
Ng [40] | 2014 | USA | pros | 51 | 27 | 67 | 52 | 65.6(7.5) | 79.3(8.1) | 3 months | Materialise | MRI | OA |
Renson [41] | 2014 | Belgium | pros | 71 | 60 | 62 | 52 | 68.2(8.9) | 70.3(8.7) | 6 months | Materialise | MRI | OA |
Dossett [42] | 2014 | USA | RCT | 44 | 44 | 7 | 14 | 66.0(7.7) | 66.0(8.6) | 24 months | Vanguard | MRI | arthritis |
Abdel [43] | 2014 | France | RCT | 20 | 20 | 60 | 60 | 71.0(61–81) | 71(55–83) | 3 months | Materialise | MRI | arthritis |
Chotanaphuti [44] | 2014 | Thailand | RCT | 40 | 40 | 88 | 88 | 69.7(5.5) | 69.3(5.5) | 1.5 months | TruMatch | CT | arthritis |
Pfitzner [45] | 2014 | USA | RCT | 60 | 30 | 57 | 57 | 64.0(54–74) | 64.0(54–74) | 3 months | Visionaire | MRI | OA |
Woolson [46] | 2014 | USA | RCT | 22 | 26 | 0 | 0 | NR | NR | 9 months | TruMatch | CT | no |
Nabavi [47] | 2015 | Australia | retro | 82 | 84 | 52 | 52 | 64(44–85) | 65(45–88) | 12 months | MyKnee | CT | no |
Thienpont [48] | 2015 | Belgium | retro | 75 | 75 | 67 | 67 | 65.6(9.6) | 67.8(11.0) | 1.5 months | Visionaire | NR | OA |
Yan [49] | 2015 | China | RCT | 30 | 30 | 57 | 80 | 67.5(8.0) | 69.5(8.4) | 3 months | Materialise | MRI | OA* |
Chen [50] | 2015 | Singapore | pros | 29 | 30 | 69 | 83 | 65.0(8.0) | 65.0(8.0) | 24 months | Materialise | MRI | OA |
Kotela [51] | 2015 | Poland | RCT | 49 | 46 | 67 | 72 | 66.1(8.4) | 68.6(9.9) | 12 months | Signature | CT | OA |
Rathod [52] | 2015 | USA | retro | 15 | 14 | 60 | 57 | 57.0(4.5) | 59.0(6.5) | 3 months | Visionaire | MRI | OA |
Abane [53] | 2015 | France | RCT | 70 | 70 | 43 | 39 | 67.8(47–84) | 70.4(54–83) | 3 months | Visionaire | MRI | OA |
Molicnik [54] | 2015 | Slovenia | RCT | 19 | 19 | 89 | 74 | 67.1(7.1) | 66.8(6.7) | NR | Materialise | MRI | OA |
Ferrara [55] | 2015 | Italy | RCT | 15 | 15 | 60 | 53 | 75.3(6.7) | 74.5(7.2) | NR | Materialise | MRI | OA |
Anderl [56] | 2016 | Austria | pros | 114 | 108 | 64 | 58 | 68.7(8.2) | 67.7(9.6) | 24 months | MyKnee | CT | OA |
Boonen [57] | 2016 | Netherlands | RCT | 90 | 90 | 62 | 56 | 69.0(8.0) | 65.0(8.8) | 44 months | Signature | MRI | OA |
Huijbregts [58] | 2016 | Australia | RCT | 69 | 64 | 58 | 50 | 66.7 (9.1) | 69.0(9.6) | 12 months | Visionaire | MRI | arthritis |
Pourgiezis [59] | 2016 | Australia | pros | 45 | 45 | 80 | 56 | 69.5(1.5) | 69.3(1.5) | 3 months | Visionaire | MRI | OA |
White [60] | 2016 | USA | pros | 21 | 42 | 67 | 67 | 59.1(7.4) | 59.8(6.7) | 24 months | iTotal | CT | OA |
Culler [61] | 2017 | USA | retro | 126 | 122 | 62 | 64 | 69.7(8.4) | 68.3(9.5) | 3 months | NR | CT | arthritis |
Kwon [62] | 2017 | Korea | retro | 48 | 50 | 96 | 94 | 73.0(4.3) | 72.0(6.5) | 3 months | Signature | MRI | OA |
Zhu [63] | 2017 | Singapore | pros | 42 | 48 | 71 | 77 | 69.3(7.2) | 66.8(5.9) | 24 months | TruMatch | CT | OA |
Vide [64] | 2017 | Portugal | RCT | 47 | 48 | 68 | 69 | 67.8(8.4) | 69.3(6.5) | NR | Visionaire | MRI | OA |
Kosse [65] | 2018 | Netherlands | RCT | 21 | 21 | 62 | 43 | 62.7(4.5) | 63.4(4.2) | 12 months | Visionaire | MRI | OA |
Steimle [66] | 2018 | USA | retro | 31 | 49 | NR | NR | 60.8(8.5) | 61.0(9.9) | NR | Materialise | MRI | OA |
Tammachote [67] | 2018 | Thailand | RCT | 54 | 54 | 78 | 72 | 72.0(7.0) | 72.0(8.0) | 24 months | Visionaire | MRI | arthritis |
Maus [68] | 2018 | Germany | RCT | 59 | 66 | 56 | 65 | 68.1(8.5) | 71.5(8.1) | 3 months | Imprint | MRI | OA |
Stolarczyk [69] | 2018 | Poland | RCT | 30 | 30 | 73 | 60 | 70.2(5.9) | 69.6(7.1) | 3 months | Visionaire | MRI | OA |
Leeuwen [70] | 2018 | Norway | RCT | 44 | 50 | 68 | 64 | 67.0(8.8) | 64.0(6.9) | 24 months | Signature | MRI | OA |
NCT02539992 [71] | NR | Italy | RCT | 26 | 18 | 38 | 44 | NR | NR | 12 months | Triathlon | MRI | OA |